Adial Pharmaceuticals Stock Price Prediction
| ADIL Stock | USD 2.17 0.15 6.47% |
Oversold Vs Overbought
37
Oversold | Overbought |
Adial Pharmaceuticals stock price prediction is an act of determining the future value of Adial Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Adial Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Adial Pharmaceuticals and does not consider all of the tangible or intangible factors available from Adial Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Adial Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Adial Pharmaceuticals' stock price prediction:EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (1.99) | EPS Estimate Next Year (1.59) | Wall Street Target Price 17 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Adial Pharmaceuticals based on different types of headlines from major news networks to social media. The Adial stock price prediction module provides an analysis of price elasticity to changes in media outlook on Adial Pharmaceuticals over a specific investment horizon. Using Adial Pharmaceuticals hype-based prediction, you can estimate the value of Adial Pharmaceuticals from the perspective of Adial Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Adial Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Adial Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Adial because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Adial Pharmaceuticals after-hype prediction price | USD 2.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Adial |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adial Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adial Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Adial Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adial Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adial Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Adial Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Adial Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adial Pharmaceuticals' historical news coverage. Adial Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.10 and 22.76, respectively. We have considered Adial Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Adial Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Adial Pharmaceuticals is based on 3 months time horizon.
Adial Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Adial Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adial Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adial Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.30 | 20.71 | 0.12 | 1.52 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.17 | 2.05 | 5.53 |
|
Adial Pharmaceuticals Hype Timeline
Adial Pharmaceuticals is presently traded for 2.17. The entity has historical hype elasticity of -0.12, and average elasticity to hype of competition of 1.52. Adial is forecasted to decline in value after the next headline, with the price expected to drop to 2.05. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -5.53%, whereas the daily expected return is presently at 2.3%. The volatility of related hype on Adial Pharmaceuticals is about 3129.97%, with the expected price after the next announcement by competition of 3.69. The book value of the company was presently reported as 2.46. The company recorded a loss per share of 4.91. Adial Pharmaceuticals had not issued any dividends in recent years. The entity had 1:25 split on the 7th of August 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Adial Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Adial Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Adial Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Adial Pharmaceuticals' future price movements. Getting to know how Adial Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adial Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ALKS | Alkermes Plc | 0.36 | 9 per month | 0.00 | (0.09) | 2.79 | (4.24) | 21.89 | |
| IRWD | Ironwood Pharmaceuticals | 0.31 | 12 per month | 0.00 | (0.10) | 3.82 | (4.53) | 42.91 | |
| DCPH | Deciphera Pharmaceuticals LLC | (0.12) | 10 per month | 2.52 | (0.02) | 4.84 | (4.32) | 17.94 | |
| EGRX | Eagle Pharmaceuticals | (0.40) | 10 per month | 4.87 | 0.03 | 8.00 | (7.92) | 23.10 | |
| NBIX | Neurocrine Biosciences | 4.08 | 10 per month | 1.56 | (0.04) | 2.61 | (2.36) | 8.06 | |
| DVAX | Dynavax Technologies | (0.26) | 9 per month | 0.00 | (0.27) | 2.49 | (2.90) | 6.78 |
Adial Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Adial price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adial using various technical indicators. When you analyze Adial charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Adial Pharmaceuticals Predictive Indicators
The successful prediction of Adial Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adial Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adial Pharmaceuticals based on analysis of Adial Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adial Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adial Pharmaceuticals's related companies. Story Coverage note for Adial Pharmaceuticals
The number of cover stories for Adial Pharmaceuticals depends on current market conditions and Adial Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Adial Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Adial Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Adial Pharmaceuticals Short Properties
Adial Pharmaceuticals' future price predictability will typically decrease when Adial Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Adial Pharmaceuticals often depends not only on the future outlook of the potential Adial Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adial Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.4 M | |
| Cash And Short Term Investments | 2.8 M |
Check out Adial Pharmaceuticals Basic Forecasting Models to cross-verify your projections. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Adial Stock analysis
When running Adial Pharmaceuticals' price analysis, check to measure Adial Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adial Pharmaceuticals is operating at the current time. Most of Adial Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Adial Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adial Pharmaceuticals' price. Additionally, you may evaluate how the addition of Adial Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Adial Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.91) | Return On Assets (0.82) | Return On Equity (1.90) |
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.